Gimv

VirtenSys was formed in 2005 to address a key problem in the IT industry. The IT industry today is caught between a 'rock and a hard place'. On one side IT budgets are severely constrained with analysts predicting single figure percentage growth for the foreseeable future. IT providers are expected to deliver increased value both in terms of reduced asset cost and 'Total Cost of Ownership'. This TCO factor is becoming dominated by issues like floor space, power consumption, thermal management and system maintenance costs. At the same time the workload on IT systems is increasing much faster than the budgets. More importantly however, the dynamics of the workload are also changing. Successful companies need to be more agile in responding to changing business conditions and need an IT infrastructure which can adapt equally fast. New business models are also emerging with analysts predicting that by 2010, 25% of all IT services will be supplied through utility computing models, requiring even more dynamic workload capabilities. To add to this challenge, the size of the industry, particularly with respect to the investment in software and systems, demands an evolutionary forward migration path. The industry does not tolerate 'fork lift' upgrades.

MEGA International S.A., a software development company, develops and markets a range of software solutions to manage enterprise complexity for Fortune 500 companies, SMEs, and government agencies globally. It offers HOPEX, an integrated software solution for business process analysis, IT portfolio management, governance, risk and compliance, and platform and shared services. The company also provides HOPEX Cloud, an integrated cloud platform for software solutions to help drive business and IT transformation. In addition, it offers EAMS assessment, design, implementation, support, and training services. The company serves banking and insurance, defense and security, energy and manufacturing, government, pharma, food and chemical, retail, and telecoms and services customers. It serves its customers through a network of distributors worldwide. The company was founded in 1991 and is based in Paris, France with additional offices in the United States, Italy, Germany, the United Kingdom, México, Singapore, Morocco, and Australia.

Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

Movea is a provider of motion sensing and data fusion software, firmware, and IP for the consumer electronics, particularly smart phones and tablets, sports and fitness and eHealth industries. Movea's proprietary SmartMotion™ technology - unique motion processing capabilities - enable customers and partners to quickly add motion intelligence to their products, providing reduced risk, cost, and time-to-market advantages for delivering compelling new motion-based features that create more value and a more exciting user experience for the consumer. Movea has a global presence with headquarters in Grenoble, France, a U.S. subsidiary in Silicon Valley, California, as well as technology and manufacturing partners and distributors around the world. The company was recently named a “Cool Vendor for 2012” by leading analyst firm Gartner Inc. Movea, Inc. was formerly known as Gyration, Inc. and changed its name to Movea, Inc. in January 2008. The company was founded in 1989 and is based in Milpitas, California. As of December 21, 2007, Movea, Inc. operates as a subsidiary of Movea SA.

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.

ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.

Agrobiothers Laboratoire SAS engages in the production and distribution of animal hygiene and care products as well as pet accessories. The company was founded in 1880 and is based in Cuisery, France.

ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs. AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of the disease process. This is paving the way for novel CNS therapeutics and future growth for AGY.

Prosonix Ltd. operates as a specialty pharmaceutical company, which develops and markets a portfolio of inhaled respiratory medicines to treat asthma and chronic obstructive pulmonary diseases. It develops generic mono and combination therapies based on inhaled corticosteroids (ICS), long-acting beta agonists (LABA), and long-acting muscarinic antagonists (LAMA); and dual and triple combination therapies for respiratory diseases based on its multiple-component particle technology. The company was founded in 2006 and is based in Oxford, United Kingdom. As of June 15, 2015, Prosonix Ltd. operates as a subsidiary of Circassia Limited.

General Fusion Inc. develops commercial Magnetized Target Fusion, a hybrid between magnetic fusion and inertial confinement fusion for transforming energy supply. It also develops scale subsystems, including scale plasma injectors, acoustic drivers, and liquid metal vortex compression tests. The company was founded in 2002 and is based in Burnaby, Canada.

Liquavista B.V., a display manufacturing company, develops electro-wetting displays in the Netherlands and internationally. It offers LiquavistaBright that offers a combination of brightness in natural light and bold contrast to video; LiquavistaColor, which enables eReader devices to offer bright, full color, and low power video capable displays; and LiquavistaVivid, a transflective mode display, which represents the eReader application. Its products are used in portable and mobile applications, such as phones, watches, cameras, DVD players, and automotive applications. The company was founded in 2006 and is based in Eindhoven, the Netherlands with additional offices in the Netherlands, the United Kingdom, and Hong Kong.

Breath Therapeutics – a Zambon Group Company is pursuing groundbreaking therapies by unleashing the true potential of inhaled drug delivery. Their approach combines novel formulations of existing drugs with cutting-edge inhalation technology for the treatment of rare respiratory diseases with high unmet medical need. They are developing drug-device combinations designed to rapidly deliver high concentrations of drugs to the site of action in the lung. Their approach increases effective dosing in the lung while minimizing systemic exposure which could lead to new treatment solutions with enhanced efficacy and safety.

TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.

One of A Kind Technologies B.V. is a holding company. The company, through its subsidiaries, develops camera inspection technology, vision solutions, and industrial automation products. The company is headquartered in Eindhoven, the Netherlands.

Laser 2000 Gesellschaft zum Vertrieb von Lasern, optoelektronischen Komponenten und Systemen mbH distributes optical products for research laboratories and industries involved in photonics in Europe. It offers lasers and lightsources, optics and optomechanics, laser safety products, optical instrumentation products, optical detectors, and UV technology products. The company also provides infrared technology products, machine vision products, network technology products, digital testing products, fiber optics, and ophthalmic systems. In addition, it offers acousto-optical equipment, motorized components, optical simulation software solutions, OEM-solutions, vacuum compatible components, and filters. Further, the company provides leasing services. Laser 2000 Gesellschaft zum Vertrieb von Lasern, optoelektronischen Komponenten und Systemen mbH was founded in 1986 and is based in Starnberg, Germany. The company has additional offices in Berlin, Dresden, Mönchengladbach, and Chemnitz. The company has locations in France, Switzerland, the United Kingdom, Belgium, Holland, and Sweden.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Operator Groep Delft B.V. provides IT outsourcing, IT projects, consulting, and staffing services. The company offers ICT solutions, such as software development, ICT infrastructure, business intelligence, service desk, cloud hosting, online workplace, and application management services. It serves education institutions, government and non-profit organization, business market, and health care sector. The company was founded in 1987 and is based in Delft, the Netherlands.

VirtenSys was formed in 2005 to address a key problem in the IT industry. The IT industry today is caught between a 'rock and a hard place'. On one side IT budgets are severely constrained with analysts predicting single figure percentage growth for the foreseeable future. IT providers are expected to deliver increased value both in terms of reduced asset cost and 'Total Cost of Ownership'. This TCO factor is becoming dominated by issues like floor space, power consumption, thermal management and system maintenance costs. At the same time the workload on IT systems is increasing much faster than the budgets. More importantly however, the dynamics of the workload are also changing. Successful companies need to be more agile in responding to changing business conditions and need an IT infrastructure which can adapt equally fast. New business models are also emerging with analysts predicting that by 2010, 25% of all IT services will be supplied through utility computing models, requiring even more dynamic workload capabilities. To add to this challenge, the size of the industry, particularly with respect to the investment in software and systems, demands an evolutionary forward migration path. The industry does not tolerate 'fork lift' upgrades.

Multiplicom is a Belgian start-up that focuses on molecular diagnostics.

Elixent, Ltd. supplies reconfigurable arithmetic processors in the United Kingdom. It offers reconfigurable semiconductor intellectual property, a technology that enables user to change the function of a chip even when in use. The company also offers silicon devices and supporting software. In addition, the company provides D-Fabrix, a reconfigurable algorithm processing technology that provides application specific integrated circuit designers with an alternative to fixed function chips; and reprogrammable algorithm solutions for system on chip platforms. Elixent, Ltd. is a spin off of Hewlett-Packard's Bristol Research Laboratories. The company was founded in October 2000 and is based in Bristol, the United Kingdom.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

JenaValve's device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation. At a very early state, it became clear to their research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense's TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.

Proficient Systems is a leading enterprise software company that develops solutions enabling companies to increase revenue and sales productivity. By identifying and connecting online sales opportunities with offline sales and service operations Proficient enables companies to successfully drive new customer acquisition, lead generation and an improved online customer experience. Headquartered in Atlanta, Georgia, Proficient was founded by successful entrepreneur, Gregg Freishtat. Gregg recognized that large enterprises selling complex, consultative products and services, like mortgages or insurance, had made significant investments in their e-business and in their sales and service organizations - but for some reason the two weren't connected. His belief was that if the two were connected, the enterprises would see a significant increase in revenue while delivering superior customer service and a better customer online experience. With this belief in mind, he assembled a group of professionals with decades of experience creating and delivering solutions to large enterprises, to create a strategic business solution to meet these objectives. In October 2000, Proficient was born. Today, organizations are benefiting from Gregg's vision and his ability to create a company to make his vision become a reality.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Ubidyne was formed in 2005 to bring its groundbreaking digital Antenna Embedded Radioâ„¢ technology to market. Ubidyne's products will be available from Nokia Siemens Networks as part of their Flexistation product family. The Ubidyne integrated active antenna systems are compatible with CPRI and OBSAI optical interfaces and support current and next-generation standards including GSM, UMTS, HSPA+, and LTE. Ubidyne's micro-radio technology is integrated within wireless antennas and revolutionizes the economics of mobile communications. This eliminates the need for coaxial feeder cables, remote electrical tilt and additional amplifiers on antenna towers and masts. The Ubidyne technology significantly reduces energy consumption while improving radio performance, deployment flexibility, coverage and capacity of mobile communications networks globally.

Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that are difficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.

Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Nomadesk is a European SaaS company, founded in 2004 and focused on Business File Sharing & Synchronization technology.  We are leading developers of cloud software for sharing and synchronizing digital documents, allowing foremost business users to edit, share, synchronize and secure files from anywhere – online and offline! Our company maintains datacenter facilities in Europe (Frankfurt, Amsterdam) and USA (Asheville – NC) for our European and American customers, respectively. ​ Nomadesk mainly targets resellers, service providers and system integrators, who offer the Nomadesk solutions to their clients – usually under a proprietary name, or brand. ​ Nomadesk is part of UnifiedPost, an international BPaaS provider of integrated business process optimisation solutions including complete document delivery and processing solutions, complemented by payment, financial supply chain, credit management and secure e-identity solutions.

Smart Battery Solutions GmbH develops and manufactures energy storage systems and charging technologies. The company offers unipower/unipower light products, LBP-Xell products, batteries, chargers, and cells. Its products are used for various e-mobility applications, including e-bikes, e-scooters, watercraft, and drones, as well as stationary solutions, such as constant power supply devices. The company was founded in 2010 and is based in Kleinostheim, Germany.

Financiere du Grand Comptoir was incorporated in 2007 and is based in Hérouville-Saint-Clair, France. Financiere du Grand Comptoir operates as a subsidiary of LEGALLAIS - S.A.S.

Summa's rich history began in a Gistel, Belgium factory in 1973. The factory was established to assemble high-tech recording devices used in, among other things, the manufacture of precision optical lenses. Summa's evolution into vinyl imaging started in 1987, when it began modifying pen-plotters for use in vinyl-cutting applications. That evolution led to what Summa is today, a recognized global leader in vinyl cutting and imaging equipment for the sign, outdoor advertising and aerospace markets.

Private Outlet SAS engages in the online retail of apparel for men, women, and children in France, Germany, Austria, Belgium, Spain, Ireland, Italy, Luxembourg, the Netherlands, Portugal, and the United Kingdom. It offers ready to wear clothing, footwear, accessories, fashion products, decoration products, jewelry, high-tech products, appliances, sports products, beauty products, house products, and lingerie for its members. The company was founded in 2006 and is based in Saint-Denis, France. Private Outlet SAS operates as a subsidiary of Andrino.

Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is also tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.

Fovea Pharmaceuticals is a French biopharmaceutical company. It discovers and develops drugs for the treatment of ocular diseases. The company offers FOV1101 Prednisporin for the treatment of allergic conjunctivitis; FOV2302, a proprietary plasma kallikrein-kinin inhibitor for the systemic treatment of hereditary angioedema; FOV2304 for the treatment of diabetic macular edema; and FOV2501, an intravitreal formulation of RdCVF designed to treat retinitis pigmentosa with extension to dry age-related macular degeneration. Fovea Pharmaceuticals was founded in 2005 and is based in Paris, France. As of October 30, 2009, it operates as a subsidiary of Sanofi.

XL Video, an Ostend-belgim-based global player in the rental of video display systems for concerts, shows and other events. Founded in 1996 and led by CEO and co-founder René de Keijzer, XL Video is an international leading player in the rental of video technology, such as video screens, for major concert tours, trade fairs, TV shows, sports and other events. The group has a large stocks of high-end video technology such as video displays (LED, projection, plasma and LCD), HD camera systems and large trucks with built-in video screens. XL Video also develops and sells its own LED systems (Pixled).

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Liquavista B.V., a display manufacturing company, develops electro-wetting displays in the Netherlands and internationally. It offers LiquavistaBright that offers a combination of brightness in natural light and bold contrast to video; LiquavistaColor, which enables eReader devices to offer bright, full color, and low power video capable displays; and LiquavistaVivid, a transflective mode display, which represents the eReader application. Its products are used in portable and mobile applications, such as phones, watches, cameras, DVD players, and automotive applications. The company was founded in 2006 and is based in Eindhoven, the Netherlands with additional offices in the Netherlands, the United Kingdom, and Hong Kong.

Micron Ventures is a venture capital arm of Micron Technology, Inc. specializing in early stage investments. It seeks to invest in startups. The firm seeks to invest in technology companies particularly memory solutions, system-level solutions, semiconductor processing solutions, imaging technologies, embedded applications, computing, wireless, and other disruptive semiconductor technologies. The firm prefers to make investments of $100 million for a period of ten years in the portfolio companies. Micron Ventures was founded in 2006 and is based in Boise, Idaho. Micron Ventures operates as an investment arm of Micron Technology, Inc.

Multiplicom is a Belgian start-up that focuses on molecular diagnostics.

Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

McPhy Energy S.A. develops and supplies hydrogen production, storage, and distribution equipment for hydrogen energy, zero emission mobility, and industrial hydrogen markets worldwide. The company offers alkaline electrolyzers, including small, medium, and large hydrogen production units; and hydrogen storage solutions. It also designs medium and large hydrogen stations; and integrated hydrogen solutions. The company was founded in 2008 and is based in La Motte, France.

La Comtoise develops and supplies tailor-made cheese solutions to industrial food processing groups.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Laser 2000 is an independent European suppliers of innovative laser and photonics solutions. The company's comprehensive range of products extends from lasers and light sources for the processing of materials, over measurement equipment and fibre optics to 3D imaging, optical power and energy meters as well as cameras. With more than 30 years of experience in the market, Laser 2000 is a photonics pioneer and can therefore benefit from long-standing customer and supplier relationships. It serves renowned companies and research institutes in the fields of automation and sensor technology, optical communications and network technologies, biotech and medicine, automotive and aerospace.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Ceres is a non-profit organization that advocates for sustainability leadership. The organization mobilizes a network of investors, companies, and public interest groups to accelerate and expand the adoption of sustainable business practices and solutions to build a healthy economy. It also carries out research in business sustainability trends as well as insurance and banking sector responses to climate change, electric utilities emissions, fuel economy standards, and climate risk disclosure. Ceres is headquartered in Boston, Massachusetts.

SYNOX THERAPEUTICS LIMITED is a clinical stage biopharmaceutical company, focused on the clinical development of new therapies to treat cancer. Its clinical product includes emactuzumab, a clinical-stage humanised IgG1 CSF-1R targeted antibody designed to target and deplete macrophages in the tumour tissue. SYNOX THERAPEUTICS LIMITED was incorporated in 2019 and is based in Dublin, Ireland.

The group France Thermes is the organizing body of all operating subsidiaries, which include: The Thermal Resorts of Bagnoles de l'Orne (Normandy) and Châtel-Guyon (Auvergne) since January 1, 2017. The group is founded on a multi-expertise in the thermal environment, around three main skills:

Arrow Therapeutics was founded in 1998 and is already making a significant contribution to anti-infective drug discovery. Microbial resistance to existing drugs is an ever increasing threat that is leading to serious unmet medical need and incurring a huge financial burden on society. Despite the huge challenges of this situation it also presents excellent opportunities to combine scientific research and business. As more and more big pharma groups concentrate their efforts on drug development, greater chances are open to smaller companies such as ours to show their excellence in research.

Medi-Markt is the specialist for medical aids and care aids.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Oldelft B.V. manufactures transesophageal echocardiography (TEE) ultrasound transducers, which are used in the adult, pediatric, and neonatal cardio markets for diagnosis and monitoring of the heart. The company offers matrix TEE probe, motorized adult multiplane TEE probe, minimulti pediatric TEE transducer, micromulti TEE probe, and adult multiplane TEE transducer. The company is based in Delft, Netherlands.

Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Equipe Zorgbedrijven Holding B.V. operates clinics for specialized surgery in the Netherlands. The company is headquartered in Eindhoven, the Netherlands.

GTX Medical is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Software and consulting services to ip, semiconductor and electronics companies

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Proficient Systems is a leading enterprise software company that develops solutions enabling companies to increase revenue and sales productivity. By identifying and connecting online sales opportunities with offline sales and service operations Proficient enables companies to successfully drive new customer acquisition, lead generation and an improved online customer experience. Headquartered in Atlanta, Georgia, Proficient was founded by successful entrepreneur, Gregg Freishtat. Gregg recognized that large enterprises selling complex, consultative products and services, like mortgages or insurance, had made significant investments in their e-business and in their sales and service organizations - but for some reason the two weren't connected. His belief was that if the two were connected, the enterprises would see a significant increase in revenue while delivering superior customer service and a better customer online experience. With this belief in mind, he assembled a group of professionals with decades of experience creating and delivering solutions to large enterprises, to create a strategic business solution to meet these objectives. In October 2000, Proficient was born. Today, organizations are benefiting from Gregg's vision and his ability to create a company to make his vision become a reality.

Cegeka’s mission is to help customers survive and thrive in a world where the rules of the game are constantly changing. Cegeka is an independent European IT services provider. The company helps its customers with IT consultancy projects, the integration of ICT infrastructure, the development and implementation of applications and outsourcing. The ICT company, originally Belgian, houses the ICT of its customers in its own data centres in Hasselt, Leuven and Veenendaal (the Netherlands). A new, state-of-the-art data centre is opening in the Dutch city of Geleen at the end of 2015. Cegeka Group has over 3500 employees, and is expecting a consolidated turnover of €400m in 2015. Cegeka has branches in Belgium, Germany, France, Italy, the Netherlands, Luxembourg, Austria, Poland, Romania, Slovakia and the Czech Republic.

Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

GreenPeak Technologies BV, a fabless semiconductor/system company, develops ultra-low power wireless data communication controller chips for smart home applications and consumer electronics. It provides communication controller semiconductor products and software technologies for smart home data communications; a range of IEEE 802.15.4 and ZigBee silicon solutions; and Senior Lifestyle sensor and cloud based intelligent system technology to enable children and their elderly parents to privately and securely share lifestyle information. The company also offers integration, support, and training services. It markets and sells its products to OEMs and ODMs in the United States, Europe, Asia, and Latin-America. GreenPeak Technologies BV has a strategic partnership with Sensara. GreenPeak Technologies BV was formerly known as Xanadu Wireless BV and changed its name to GreenPeak Technologies BV in 2007. The company was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, China, France, the United States, Japan, and Korea. As of April 29, 2016, GreenPeak Technologies BV operates as a subsidiary of Qorvo, Inc.

Nomadesk is a European SaaS company, founded in 2004 and focused on Business File Sharing & Synchronization technology.  We are leading developers of cloud software for sharing and synchronizing digital documents, allowing foremost business users to edit, share, synchronize and secure files from anywhere – online and offline! Our company maintains datacenter facilities in Europe (Frankfurt, Amsterdam) and USA (Asheville – NC) for our European and American customers, respectively. ​ Nomadesk mainly targets resellers, service providers and system integrators, who offer the Nomadesk solutions to their clients – usually under a proprietary name, or brand. ​ Nomadesk is part of UnifiedPost, an international BPaaS provider of integrated business process optimisation solutions including complete document delivery and processing solutions, complemented by payment, financial supply chain, credit management and secure e-identity solutions.

MVZ Holding focusses on providing best in class primary medical care and has grown successfully by executing a disciplined expansion strategy. The company currently runs more than 25 medical practices in different regions in Switzerland and plans further expansion within the country.

Psytechnics is a leading authority for voice and video service management. The company offers a range of active and passive software solutions for both Enterprises and Service Providers markets. These software solutions are used to demonstrably improve the performance of real-time communications, including the most advanced unified communications applications and networks designs. Psytechnics' software is specially calibrated for voice, video (from softclient to Telepresence), and fixed-mobile services. The company's core product, Experience Manager, is the first IT service management solution that monitors, alarms, diagnoses and reports on services based on users QoE (Quality of Experience). The software is prized as highly accurate and intuitive, and supports communications platforms from any vendor, including Cisco, Avaya, Nortel, Genband, Polycom, Tandberg, Radvision, Acme Packet, IBM Sametime, Microsoft, and others.

Arseus Medical B.V. distributes medical equipment and consumables to hospital. Its products include medical devices, disposables, hygiene and disinfection products, medical instruments and small diagnostic materials, lab and testing materials, reagents, catheters, surgery equipment, instruments products, and disposables. Arseus Medical B.V. was formerly known as Omega Medical BV. The company was founded in 2002 and is based in Waalwijk, the Netherlands. Arseus Medical B.V. is a former subsidiary of Fagron NV.

Openbravo is a world leader in the commercial open source software space helping midsize and large specialty retailers around the globe successfully manage continuous business change and innovation in today's fast-changing retail industry. Openbravo offers the Openbravo Commerce Suite, a multichannel retail business solution that allows specialty retailers to manage their entire business and transform their physical store channel to deliver great shopping experiences, while enabling more focus on business differentiation thanks to a highly flexible and extendible commerce technology platform, which is mobile-enabled and cloud-ready. Openbravo has offices in France, India, Mexico and Spain and distributes its software solutions through a global network of Authorized Partners.

Stiplastics S.A.S. engages in designing, developing, and manufacturing medical devices for the healthcare industry in France and internationally. It offers distributor pumps, containers, tamper-proof containers, liners for caps, caps, closures, cosmetic spatulas, nozzles and droppers, spoons, IML measuring scoops, measuring spoons, measuring cups, dosing systems, special dosing systems, transportation boxes, and specific packaging products; pharmaceutical packaging products, carrying cases for biological samples, and pillboxes; and more. The company provides its products through its catalog. Stiplastics S.A.S. was founded in 1985 and is based in Beauvoir-en-Royans, France.

Launched in 2007 by entrepreneur and mother of five Nathalie Christen-Genty, MELIJOE.COM is the world’s premier online fashion e-tailer for children ages 0-16. Featuring the latest in childrenswear trends inspired directly by adult runways, MELIJOE.COM is home to some of the industry’s most sought-after labels in kid’s fashion. MELIJOE.COM is above all an international brand, featuring 100% authentic products, speedy worldwide shipping and a website translated in six languages. Thanks to a developed editorial strategy and magazine-inspired web layout, MELIJOE.COM doubles as a digital news outlet for children’s fashion with Le Magazine, and between exclusive shopping edits, childrenswear news, trend reports and in-house photo shoots, MELIJOE.COM is an extra-large world of digital fashion for the smallest of fashionistas.

Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

ALRO NV is engaged in coating plastics and metal parts for cars, trucks, industrial vehicles, telecom, and other industries. It provides pretreatment, electro coating, wet painting, powder coating, high gloss black powder coating, assembly, and waste treatment services. The company serves automotive OEM, trucks OEM, plastic industry, and metal industry markets. ALRO NV was founded in 1976 and is based in Dilsen-Stokkem, Belgium.

WEMAS is market leader in Germany for integrated, certified solutions for road shut-off technology. The broad range of products mainly includes shutters, fall arrestors, lights, footplates and traffic cones. The core business is supplemented by other plastic products such as mortar baths, protective devices for the logistics sector, as well as articles for horse sport. The sales are exclusively for customers as well as for the trade. At the headquarters in Gütersloh, more than 120 employees work on the satisfaction of WEMAS customers.

JenaValve's device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation. At a very early state, it became clear to their research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

JenaValve's device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation. At a very early state, it became clear to their research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.

Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.

Almaviva Santé owns and operates hospitals and health care clinics. The company was founded in 2007 and is headquartered in Marseille, France.

One of A Kind Technologies B.V. is a holding company. The company, through its subsidiaries, develops camera inspection technology, vision solutions, and industrial automation products. The company is headquartered in Eindhoven, the Netherlands.

Arplas Europe BV engages in the development, application, and marketing of various welding-applications for the production of passenger cars worldwide. The company was founded in 1971 and is based in Amersfoort, the Netherlands with manufacturing, service, and training facilities in Europe, North America, and Korea; and service representatives in China and Brazil. It also has locations in Europe and Africa. Arplas Europe BV operates as a subsidiary of AL-S Technology B.V.

JenaValve's device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation. At a very early state, it became clear to their research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

Ellis Gourmet Burger owns and operates burger restaurants chain in Belgium, the Netherlands, and France. The company was founded in 2011 and is based in Aalst, Belgium.

Topas Therapeutics GmbH operates as a biotechnology company that is engaged in developing nanoparticle-based therapeutics. The company builds neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. The company develops nanoparticle technology to target autoimmune, allergies, anti-drug antibodies, and inflammatory diseases through the induction of antigen specific immune tolerance in the liver. The company’s platform promotes immune tolerance to blood antigens. Topas Therapeutics GmbH was incorporated in 2013 and is based in Hamburg, Germany.

ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

Snack Connection B.V. manufactures and mixes nuts, kernels, seeds, dried fruit, croutons, and rice crackers for the retailers in the Netherlands. The company was founded in 2010 and is based in Giessen, the Netherlands.

Sté Comtoise de Spécialités Fromagères develops, produces, and supplies cheese ingredients to the food-processing industry in France and internationally. It offers chesses for slicing, toppings, pizzas, sandwiches, snacking products, ready meals, etc. The company provides cheeses in various forms, including casings, slices, grated cheeses, vacuum packed blocks, IQF cubes, etc. Sté Comtoise de Spécialités Fromagères was founded in 1994 and is based in Louhans, France.

Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters. Hypnion is acquired by Eli Lilly and Company. Hypnion was founded in 2000 and is based in Worcester, Massachusetts.

The Well Services Group is a total well service provider for the oil and gas industry. By using well maintained 'state of the art' equipment and experienced personnel we can offer high quality services with a high efficiency. By being a flexible operating company we can respond fast to the costumers needs.

Prosensa is a biotech company also known as Ribpharm Inc dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics. During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology. Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.

Topas Therapeutics GmbH operates as a biotechnology company that is engaged in developing nanoparticle-based therapeutics. The company builds neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. The company develops nanoparticle technology to target autoimmune, allergies, anti-drug antibodies, and inflammatory diseases through the induction of antigen specific immune tolerance in the liver. The company’s platform promotes immune tolerance to blood antigens. Topas Therapeutics GmbH was incorporated in 2013 and is based in Hamburg, Germany.

ACCEO through its subsidiaries engages in various diversified sectors. It offers elevator engineering, accessibility diagnosis of buildings, and serves hospital markets.

Coolworld Rentals and its Heatworld division form an international cooling and heating equipment rental organisation. Coolworld offers flexible and reliable solutions to help with temporary capacity problems, events, equipment being down, or when are renovating or overhauling permanent systems. With their wide range of rental solutions, we are happy to serve and supply with the right rental cooling or heating 24/7/365.